BCL2L11 and leukemia: Although ABT-199 monotherapy was ineffective against Bim+/+ Eμ-Tcl1 Tg leukemias, combinations of GS-9820 and ABT-199 proved more effective than GS-9820 monotherapy alone (Figure 8c).